Viewing Study NCT06353191



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06353191
Status: RECRUITING
Last Update Posted: 2024-04-08
First Post: 2024-04-03

Brief Title: Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Study Overview

Official Title: Biomarkers to Predict Cancer Therapy-Related Cardiotoxicity
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study evaluates why some cancer patients but not others experience changes in heart function following treatment with chemotherapy
Detailed Description: PRIMARY OBJECTIVE

I To collect biospecimens from 1 patients who developed chemotherapy related cardiac toxicity CRCT and 2 patients who are at a high risk for developing CRCT

OUTLINE This is an observational study

Patients undergo blood sample collection and have their medical records reviewed on study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2024-00943 REGISTRY None None
19-002566 OTHER None None
P30CA015083 NIH None None
R01HL169268 NIH None None
R56HL160643 NIH Mayo Clinic in Florida httpsreporternihgovquickSearchR56HL160643